Literature DB >> 1940577

Reperfusion of ischemic skeletal muscle causes erythrocyte hemolysis and decreases subsequent oxidant-mediated lung injury.

J A Leff1, D A Kennedy, L S Terada, M Emmett, H J McCutchan, D L Walden, J E Repine.   

Abstract

A prior transient hindlimb ischemia/reperfusion (I/R) insult decreased acute lung injury in rats subsequently treated with cobra venom factor. I/R-mediated protection was associated with erythrocyte hemolysis, increased plasma catalase activity, and increased plasma hydrogen peroxide scavenging activity. In contrast, hindlimb I/R did not increase lung catalase activity, and large amounts of injected catalase were required to increase lung catalase activity. The results suggest that limited I/R in one organ can induce systemic processes that may decrease a subsequent O2 metabolite-mediated injury in another distant organ. The mechanism may involve release of catalase from hemolyzed erythrocytes at levels that are not sufficient to measurably increase total lung catalase activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940577

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  4 in total

Review 1.  The electrophile responsive proteome: integrating proteomics and lipidomics with cellular function.

Authors:  Ashlee N Higdon; Aimee Landar; Stephen Barnes; Victor M Darley-Usmar
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

2.  Xanthine oxidase contributes to lung leak in rats subjected to skin burn.

Authors:  L K Burton; S E Velasco; A Patt; L S Terada; J E Repine
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

3.  Increased serum catalase activity in rats subjected to thermal skin injury.

Authors:  J A Leff; L K Burton; E M Berger; B O Anderson; C P Wilke; J E Repine
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

Review 4.  Linking Labile Heme with Thrombosis.

Authors:  Marie-Thérèse Hopp; Diana Imhof
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.